04/19/2024
3:31 PM | Gilead Sciences (Reporting)
LEAP THERAPEUTICS, INC. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | Gilead Sciences (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
04/05/2024
3:31 PM | Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
| Form SC 13G | |
04/03/2024
5:48 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
5:50 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:38 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:19 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEF 14A | |
03/28/2024
3:07 PM | Gilead Sciences (Filer)
| Form DEFA14A | |
03/22/2024
8:21 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
6:50 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/20/2024
3:12 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/15/2024
3:11 PM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/12/2024
3:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:11 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:14 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:59 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:03 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:34 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T/A | |
02/29/2024
5:35 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:49 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:38 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
5:09 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-T | |
02/13/2024
4:48 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:37 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
7:39 AM | CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC TO-C | |
02/09/2024
5:21 PM | Capital World Investors (Filed by)
Gilead Sciences (Subject)
| Form SC 13G/A | |
02/07/2024
4:35 PM | Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
5:01 PM | Gilead Sciences (Issuer)
LOVE TED W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:20 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
1:42 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:34 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:19 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
1:11 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
12:40 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:58 PM | Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
01/31/2024
4:00 PM | Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Gilead Sciences (Subject)
| Form SC 13G/A | |
01/17/2024
5:01 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:32 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:35 PM | Gilead Sciences (Subject)
Mercier Johanna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
12/29/2023
3:36 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:06 PM | Arcellx, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC 13G/A | |
12/28/2023
4:09 PM | Arcellx, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2023
3:07 PM | Gilead Sciences (Reporting)
HOOKIPA Pharma Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2023
6:00 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:04 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:08 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:10 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:15 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
5:21 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:18 PM | Gilead Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
4:56 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2023
6:15 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2023
4:18 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D | |
10/19/2023
2:33 PM | Gilead Sciences (Filed by)
Ikena Oncology, Inc. (Subject)
| Form SC 13G | |
10/18/2023
3:31 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:18 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023
7:09 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
8:00 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
5:50 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:21 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
7:37 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:40 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:44 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:11 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
7:19 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:09 PM | Gilead Sciences (Filer)
| Form 424B5 | |
09/07/2023
4:28 PM | Gilead Sciences (Subject)
| Form FWP | |
09/07/2023
7:29 AM | Gilead Sciences (Filer)
| Form 424B5 | |
08/16/2023
4:19 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
4:23 PM | Gilead Sciences (Filer)
| Form S-3ASR | |
07/25/2023
5:15 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
4:30 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
8:38 AM | Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SC 13D/A | |
06/30/2023
2:54 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
2:12 PM | Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
4:17 PM | Allovir, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:48 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
4:29 PM | Gilead Sciences (Subject)
Parsey Merdad (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
3:45 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:50 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
10:15 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:10 PM | BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
6:15 PM | Gilead Sciences (Issuer)
Kramer Kelly A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:02 PM | Gilead Sciences (Issuer)
Horning Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
5:13 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:47 PM | Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:51 PM | Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:53 PM | Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
4:57 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
05/02/2023
6:12 PM | Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
